Xencor Is Picking Up Analyst Support

Xencor is down some 7% in early trading today, but analysts are telling an increasingly positive story on this name

It appears that ‘Tier 4’ biotech concern named Xencor (XNCR) is picking up some analyst support over the past…

Piper Jaffray – April 26th – Reissues Overweight rating and $46 price target


Fresh Conversations